At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
LNAI Lunai Bioworks
Closed 03-18 16:00:00 EDT
0.4019
-0.1549
-27.82%
盘后0.3700
-0.0319-7.94%
19:59 EDT
High0.4990Low0.3642Vol13.44M
Open0.4724D1 Closing0.5568Amplitude24.21%
Mkt Cap9.72MTradable Cap5.91MTotal Shares24.19M
T/O5.88MT/O Rate91.38%Tradable Shares14.71M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Tivic Subsidiary Velocity Bioworks Signs San Antonio Facility Leases
Reuters  ·  03-14
Tivic Subsidiary Velocity Bioworks Signs San Antonio Facility Leases
BRIEF-Lunai Bioworks Implements Temporary Furlough Of Employees In US And Canada- SEC Filing
Reuters  ·  03-06
BRIEF-Lunai Bioworks Implements Temporary Furlough Of Employees In US And Canada- SEC Filing
Lunai Bioworks Inc - Implements Temporary Furlough of Employees in US and Canada on Feb 27, 2026 - SEC Filing
THOMSON REUTERS  ·  03-06
Lunai Bioworks Inc - Implements Temporary Furlough of Employees in US and Canada on Feb 27, 2026 - SEC Filing
Lunai Bioworks Inc - CEO and CFO Voluntarily Agree to Temporarily Defer Salary Payments During Furlough - SEC Filing
THOMSON REUTERS  ·  03-06
Lunai Bioworks Inc - CEO and CFO Voluntarily Agree to Temporarily Defer Salary Payments During Furlough - SEC Filing
Lunai Bioworks Furloughs U.S. and Canada Employees
Reuters  ·  03-06
Lunai Bioworks Furloughs U.S. and Canada Employees
Nasdaq Moves to Delist Lunai Bioworks Securities
Reuters  ·  02-24
Nasdaq Moves to Delist Lunai Bioworks Securities
Lunai Bioworks Secures U.S. Patent for AI Debiasing Framework in Drug Discovery
Reuters  ·  02-19
Lunai Bioworks Secures U.S. Patent for AI Debiasing Framework in Drug Discovery
Lunai Bioworks Inc. - Common Stock Q2 EPS $(0.08) Up From $(0.45) YoY
Benzinga  ·  02-18
Lunai Bioworks Inc. - Common Stock Q2 EPS $(0.08) Up From $(0.45) YoY
Lunai Bioworks net income loss narrows to USD 1.80 million in Q4, down 75 percent
Reuters  ·  02-18
Lunai Bioworks net income loss narrows to USD 1.80 million in Q4, down 75 percent
Lunai Bioworks CEO Showcases AI Drug Discovery Platform on CNBC
Reuters  ·  02-13
Lunai Bioworks CEO Showcases AI Drug Discovery Platform on CNBC
Nasdaq Moves to Delist Lunai Bioworks for Minimum Bid Price Violation
Reuters  ·  02-13
Nasdaq Moves to Delist Lunai Bioworks for Minimum Bid Price Violation
Lunai Bioworks Unveils AI Platform Targeting Disease Subtypes for Precision Drug Discovery
Reuters  ·  02-10
Lunai Bioworks Unveils AI Platform Targeting Disease Subtypes for Precision Drug Discovery
Lunai Bioworks startet KI-Onkologie-Pilotprojekt mit klinischem Partner
Reuters  ·  02-09
Lunai Bioworks startet KI-Onkologie-Pilotprojekt mit klinischem Partner
Lunai Bioworks (Nasdaq: Lnai) Launches AI Oncology Pilot With Clinical-Stage Partner to Analyze Randomized Phase 2 Metastatic Colorectal Cancer Survival Trial Data
THOMSON REUTERS  ·  02-09
Lunai Bioworks (Nasdaq: Lnai) Launches AI Oncology Pilot With Clinical-Stage Partner to Analyze Randomized Phase 2 Metastatic Colorectal Cancer Survival Trial Data
Lunai Bioworks Unveils AI Tool to Block Novel Chemical Weapon Designs
Reuters  ·  01-27
Lunai Bioworks Unveils AI Tool to Block Novel Chemical Weapon Designs
Lunai Bioworks Secures NIH Grant for Alcohol Use Disorder Drug Discovery Program
Reuters  ·  01-26
Lunai Bioworks Secures NIH Grant for Alcohol Use Disorder Drug Discovery Program
Lunai Bioworks Unveils AI-Driven Platform to De-Risk Drug Discovery in Complex Diseases
Reuters  ·  01-14
Lunai Bioworks Unveils AI-Driven Platform to De-Risk Drug Discovery in Complex Diseases
Lunai Bioworks Inc - Identifies Three Parkinson's Disease Subtypes
THOMSON REUTERS  ·  2025-12-09
Lunai Bioworks Inc - Identifies Three Parkinson's Disease Subtypes
Lunai Bioworks Inc - Prioritized Drug Targets in $13 Bln Parkinson's Market
THOMSON REUTERS  ·  2025-12-09
Lunai Bioworks Inc - Prioritized Drug Targets in $13 Bln Parkinson's Market
Lunai Bioworks Identifies Three Parkinson's Subtypes and Prioritizes Drug Targets
Reuters  ·  2025-12-09
Lunai Bioworks Identifies Three Parkinson's Subtypes and Prioritizes Drug Targets

Introduction

Company Name.
Lunai Bioworks
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Issue price:
--